C21 · Pharmaceuticals · Germany
New medicines launched with orphan drug designation
Germany: 14 in 2025.
- 14 Latest · Germany · 2025
- Annual Release cadence
- 1 Record · 1 region · 2025
Verified 17 Sep 2026 · 1 publisher · Next period 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
New medicines launched with orphan drug designation
Germany, 2025
Every record
1 record · 1 region · 2025. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: VFA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (VFA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Number of newly launched medicines that have received official orphan drug designation from regulatory authorities.
- Measure
- One slice of Novel active substance launches ( form: count, segment: orphan ) . Total number of novel active substances launched on the market. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Neue Medikamente in Deutschland: Innovationsbilanz 2025 | VFA | — | 1 |
Other slices of novel active substance launches
- Novel active substance launches 6
- Oncology novel active substance (NAS) launches (cumulative) 6 cumulative · oncology
- Oncology novel active substance (NAS) launches (annual) 3 oncology
- First-in-class novel active substance launches 2 first in class
- Novel active substance launches, five-year total 2 cumulative
- Chemically synthesized share of new medicine launches 1 chemical
- Cumulative cell and gene therapy launches 1 cumulative · cell and gene therapy
- Domestic-only oncology NAS launches (cumulative) 1 cumulative · domestic · oncology
- Expected annual novel active substance launches (lower bound) 1 forecast low
- Expected annual novel active substance launches (upper bound) 1 forecast high
- Expected cumulative novel active substance launches (lower bound) 1 cumulative · forecast low
- Expected cumulative novel active substance launches (upper bound) 1 cumulative · forecast high
Frequently asked questions
What is the latest new medicines launched with orphan drug designation?
Germany: 14 in 2025.
Where does this data come from?
From 1 document published by VFA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). New medicines launched with orphan drug designation [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/new-medicines-launched-with-orphan-drug-designation
"New medicines launched with orphan drug designation." StatOrigin, 2026, https://statorigin.org/indicators/new-medicines-launched-with-orphan-drug-designation. Accessed 28 Oct. 2026.
StatOrigin. "New medicines launched with orphan drug designation." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/new-medicines-launched-with-orphan-drug-designation.
@misc{statorigin_new_medicines_launched_with_orphan_drug_designation_2026, title = {New medicines launched with orphan drug designation}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/new-medicines-launched-with-orphan-drug-designation}, note = {Data set. Accessed 2026-10-28} }